АКТИВНАЯ ХИРУРГИЧЕСКАЯ ТАКТИКА В ЛЕЧЕНИИ ВАРИКОЗНЫХ  ПИЩЕВОДНО-ЖЕЛУДОЧНЫХ КРОВОТЕЧЕНИЙ У БОЛЬНЫХ ЦИРРОЗОМ ПЕЧЕНИ

T.I. Kudaybergenov; E.A. Tilekov; R.T. Egenbaev

doi:10.54890/.v4i4.1052

T.I. Kudaybergenov E.A. Tilekov R.T. Egenbaev

DOI:

https://doi.org/10.54890/.v4i4.1052

Abstract

The purpose of this study is to improve the results of surgical treatment of bleeding from the upper abdominal cavity in patients with cirrhosis through the use of active surgical tactics and a combined method of performing the operation.
An analysis of the results of surgical treatment of 62 patients with cirrhosis complicated by bleeding from the urinary tract, hospitalized at the Scientific Clinical Center of the Ministry of Health of the Kyrgyz Republic named after. M. Mamakeev. The control group consisted of 20 patients who were operated on according to M.D. Patsiora at a later stage due to the ineffectiveness of conservative treatment. In the main group of 42 patients with bleeding from the RVV, active surgical tactics were used using a combined method. The operation of M.D. Patsior was supplemented by the intraoperative introduction of a solution of ethoxysclerol in the form of microfoam into the veins of the esophagus above the ligatures and devascularization of the stomach. In the postoperative period, the effectiveness of hemostasis, the frequency of recurrence of gastrointestinal tract in the immediate and long-term periods were assessed, endoscopic monitoring of the condition of the esophageal mucosa was carried out after 6 months and after a year.
It was established that the choice of surgical tactics in favor of early surgical intervention in addition to a combined method allowed to improve the results of treatment of patients with cirrhosis with bleeding from the urinary tract. Postoperative mortality in the control and main groups was 60% and 9.5%, one-year survival rate in the control group was 37.5%, in the main group – 71.4%, respectively.

Keywords:

cirrhosis, esophageal and gastric varices, esophageal-gastric bleeding, surgical tactics.

Author Biographies

T.I. Kudaybergenov, Kyrgyz State Medical Academy named after I.K. Akhunbaev

Department of Hospital Surgery with a course of operative surgery

E.A. Tilekov, Kyrgyz State Medical Academy named after I.K. Akhunbaev, National Surgical Center named after M.M. Mamakeev at the Ministry of Health of the Kyrgyz Republic

Department of Hospital Surgery with a course of operative surgery

R.T. Egenbaev, International School of Medicine of the International University of Kyrgyzstan

Department of Special Surgical Disciplines

References

1. Киценко Е.А., Анисимов А.Ю., Андреев А.И. Современное состояние проблемы кровотечений из варикозно-расширенных вен пищевода и желудка. Вестник современной клинической медицины. 2014;7(5):89–98. [Kicenko EA, Anisimov AYu, Andreev AI. The current state of the problem of bleeding from varicose veins of the esophagus and stomach. Vestnik sovremennoj klinicheskoj mediciny /Bulletin of modern clinical medicine. 2014;7(5):89–98 (In Russ.).]

2. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017; 65(1): 310–335. https://doi.org/10.1002/hep.28906

3. Ardevol A., Ibanez-Sanz G., Profitos J, Aracil C, Castellvi JM, Alvarado E et al. Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies. Hepatology. 2018; 67(4): 1458–1471. https://doi.org/10.1002/hep.29370

4. Villanueva C., Albillos A., Genescà J, Garcia-Pagan JC, Calleja JL, Aracil C et al. β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019; 393(10181): 1597-1608. https://doi.org/10.1016/S0140-6736(18)31875-0

5. Якупов А.Ф., Сангаджиев С.Б., Мустафин Р.Р., Анисимов А.Ю. Сравнительная оценка эффективности диагностики и хирургического лечения больных портальной гипертензией. Вестник современной клинической медицины, 2013, 6(5):11-17. [Jakupov AF, Sangadzhiev SB, Mustafin RR, Anisimov AY. Comparative evaluation of the effectiveness of diagnosis and surgical treatment of patients with portal hypertension. Vestnik sovremennojklinicheskoj mediciny /Bulletin of modern clinical medicine. 2013;6(5):11-17 (in Russ.).] https://doi.org/10.20969/vskm.2013.6(5).1-170

6. Ерамишанцев А.К., Шерцингер А.Г., Киценко Е.А. Портальная гипертензия. Клиническая хирургия: национальное руководство. M.:GEOTAR-Media; 2008:626-665. [Eramishantsev AK, Sherzinger AG, Kitsenko EA. Portal hypertension. Clinical surgery: national guidelines. M.:GEOTAR-Media; 2008:626-665 (in Russ.).]

7. Шерцингер А.Г. Патогенез, диагностика, профилактика и лечение кровотечений из варикозных вен пищевода и желудка у больных портальной гипертензией [автореф. диссертации]. М.; 1986. 310 с. [Sherzinger AG. Pathogenesis, diagnosis, prevention and treatment of bleeding from varicose veins of the esophagus and stomach in patients with portal hypertension [dissertation abstract]. M.; 1986. 310 p. (in Russ.).]

8. Пациора М.Д. Хирургия портальной гипертензии. Ташкент: Медицина; 1984. 319 с. [Patsiora MD. Surgery for portal hypertension. Tashkent: Medicine; 1984. 319 p. (in Russ.).]

9. Кошевой А.П., Чирков Д.Н., Шелко О.А. Эндоскопическая микропенная склерооблитерация варикозных вен пищевода. Актуальные вопросы хирургической гепатологии: Тезисы докладов XVII международного конгресса хирургов-гепатологов России и стран СНГ. Уфа; 2010:80. Режим доступа:https://www.mediasphera.ru/ issues/flebologiya/ 2010/2/downloads/ru/031997-69762010210. [Koshevoy AP, Chirkov DN, Shelko OA. Endoscopic microfoam scleroobliteration of esophageal varicose veins. Actual issues of surgical hepatology: Abstracts of the XVII International Congress of Hepatologists of Russia and CIS countries. Ufa; 2010:80 (in Russ.).]